Stopped: DSMB recommendations, laboratory quality control (QC) issues. All lab Q/C issues addressed; DSMB approved study re-opening, but due to length of time required to address lab QC issues, insufficient follow-up time was available to complete study.
In this study, the Investigators plan to determine the optimal means to prevent or slow the progression of kidney disease among genetically at-risk northern Nigerian HIV-infected adults. Based on data from studies of diabetic kidney disease that used medications that block the renin angiotensin aldosterone system (RAAS), we plan to evaluate whether or not RAAS inhibition (using a widely available medication that blocks RAAS) in HIV-infected adults produces similarly promising results.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Regression From Microalbuminuria (uACR 30-300) to Normoalbuminuria (uACR < 30 mg/g) by Study Arm
Timeframe: 2 years
Progression From Microalbuminuria (uACR 30-300) to Macroalbuminuria (uACR > 300 mg/g) by Study Arm
Timeframe: 2 years
Mean Change in Urinary Albumin to Creatinine Ratio (uACR)
Timeframe: 2 years